Who writes this
Articles are published under the byline “Senzu Editorial” — organizational authorship by an independent research team. We are not clinicians, and nothing here is medical or dosing advice. If a credentialed reviewer contributes to a piece, that person is named on the article; absent a name, no medical review is claimed.
Independence
Senzu does not sell peptides. Our directory, price market, and testing ledger document the market rather than participate in it. That independence is the reason our evidence assessments can be neutral.
The evidence-maturity framework
Every claim is placed on four layers, in order:
- Regulatory status — approved for this exact use, investigational, or not approved.
- Human evidence — randomized outcomes, observational signals, or anecdotes.
- Replication — one study, or a consistent body of work.
- Limits — duration, population, attrition, adverse events, and conflicts.
Primary sources on every article
We cite authoritative primary sources — FDA, NIH, PubMed, ClinicalTrials.gov — and link them directly. Mechanism papers are labeled as such and never stand in for human outcomes.
Human review before publishing
Drafting may be AI-assisted, but no article is published without a named team member running our pre-publish checklist and making a real editorial pass. We publish at a steady cadence rather than in bulk.
How our data is produced
When we publish a Senzu statistic — for example a median market price across vendors — we document the method behind it: which vendors are included, the geographic market, the date range, the product definition, how outliers are treated, and the sample size. Undocumented numbers are not published.
Educational information only. See our research directory, price market, and testing ledger.